• Users Online: 2176
  • Print this page
  • Email this page
 
BRIEF COMMUNICATION
Ahead of Print

Treatment options used in COVID-19 Disease: Steroids, anticoagulants, remdesivir and/or antibiotics – Which worked better or combo was the right choice?


1 Department of Pulmonary Medicine, MIMSR Medical College, Latur, Maharashtra, India
2 Department of Internal Medicine, MIMSR Medical College, Latur, Maharashtra, India

Correspondence Address:
Shital Patil,
Department of Pulmonary Medicine, MIMSR Medical College, Latur, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jascp.jascp_25_22

Coronavirus disease 2019 (COVID-19) is the first coronavirus-related global pandemic caused by a novel severe acute respiratory syndrome coronavirus-2, and rapid evolution of the pandemic has resulted in fast-track developments in antivirals, medical management, and vaccination for use to prevent morbidity and mortality. As of today, different institutional treatment protocols and respective national guidelines have been evolved worldwide with team of medical experts and recommended for combinations of antiviral, antibiotics, steroids, and anticoagulants with variable outcomes. Combination therapy has documented better outcome with a significant reduction in mortality and morbidity and considered frontline protocol during this pandemic.


Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Patil S
    -  Narwade G
    -  Gondhali G
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed117    
    PDF Downloaded4    

Recommend this journal